SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shawna D. Persaud, Yi-Wei Lin, Cheng-Ying Wu, Hiroyuki Kagechika, Li-Na Wei, Cellular retinoic acid binding protein I mediates rapid non-canonical activation of ERK1/2 by all-trans retinoic acid, Cellular Signalling, 2013, 25, 1, 19

    CrossRef

  2. 2
    M. Rossing, Classification of follicular cell-derived thyroid cancer by global RNA profiling, Journal of Molecular Endocrinology, 2013, 50, 2, R39

    CrossRef

  3. 3
    Marius I. Ilie, Sandra Lassalle, Elodie Long-Mira, Véronique Hofman, Joséphine Zangari, Gilles Bénaim, Alexandre Bozec, Nicolas Guevara, Juliette Haudebourg, Isabelle Birtwisle-Peyrottes, José Santini, Patrick Brest, Paul Hofman, In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAF V600E mutation status and together with hypoxia-related proteins predicts aggressive behavior, Virchows Archiv, 2013, 463, 3, 437

    CrossRef

  4. 4
    A. Bommarito, P. Richiusa, E. Carissimi, G. Pizzolanti, V. Rodolico, G. Zito, A. Criscimanna, F. Di Blasi, M. Pitrone, M. Zerilli, M. C. Amato, G. Spinelli, V. Carina, G. Modica, M. A. Latteri, A. Galluzzo, C. Giordano, BRAFV600E mutation, TIMP-1 upregulation, and NF- B activation: closing the loop on the papillary thyroid cancer trilogy, Endocrine Related Cancer, 2011, 18, 6, 669

    CrossRef

  5. 5
    Clarissa Araujo Cassol, Sylvia L. Asa, Molecular pathology of thyroid cancer, Diagnostic Histopathology, 2011, 17, 3, 124

    CrossRef

  6. 6
    Leighton Stein, Jenniffer Rothschild, Jesse Luce, John K. Cowell, Geraldine Thomas, Tatania I. Bogdanova, Mycola D. Tronko, Lesleyann Hawthorn, Copy Number and Gene Expression Alterations in Radiation-Induced Papillary Thyroid Carcinoma from Chernobyl Pediatric Patients, Thyroid, 2010, 20, 5, 475

    CrossRef

  7. 7
    Carlos Alberto Scrideli, Maria Angélica Abdala Cortez, José Andres Yunes, Rosane Gomes de Paula Queiróz, Elvis Terci Valera, Juliana França da Mata, Silvia Regina Caminada Toledo, Priscila Pavoni-Ferreira, Maria Lúcia de Martino Lee, Antonio Sérgio Petrilli, Silvia Regina Brandalise, Luiz Gonzaga Tone, mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: Potential role of TIMP1 as an adverse prognostic factor, Leukemia Research, 2010, 34, 1, 32

    CrossRef

  8. 8
    Tatiana I. Ricca, Gangning Liang, Ana Paula M. Suenaga, Sang W. Han, Peter A. Jones, Miriam G. Jasiulionis, Tissue Inhibitor of Metalloproteinase 1 Expression Associated with Gene Demethylation Confers Anoikis Resistance in Early Phases of Melanocyte Malignant Transformation, Translational Oncology, 2009, 2, 4, 329

    CrossRef

  9. 9
    Ken C. Lo, Leighton C. Stein, Jenniffer A. Panzarella, John K. Cowell, Lesleyann Hawthorn, Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis, Lung Cancer, 2008, 59, 3, 315

    CrossRef

  10. 10
    Ken C. Lo, Michael R. Rossi, Jeffrey LaDuca, David G. Hicks, Yaron Turpaz, Lesleyann Hawthorn, John K. Cowell, Candidate glioblastoma development gene identification using concordance between copy number abnormalities and gene expression level changes, Genes, Chromosomes and Cancer, 2007, 46, 10
  11. 11
    K Tanaka, I Imoto, J Inoue, K Kozaki, H Tsuda, Y Shimada, S Aiko, Y Yoshizumi, T Iwai, T Kawano, J Inazawa, Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma, Oncogene, 2007, 26, 44, 6456

    CrossRef

  12. 12
    L Delys, V Detours, B Franc, G Thomas, T Bogdanova, M Tronko, F Libert, J E Dumont, C Maenhaut, Gene expression and the biological phenotype of papillary thyroid carcinomas, Oncogene, 2007, 26, 57, 7894

    CrossRef

  13. 13
    W. C. G. van Staveren, D. W. Solis, L. Delys, D. Venet, M. Cappello, G. Andry, J. E. Dumont, F. Libert, V. Detours, C. Maenhaut, From The Cover: Gene expression in human thyrocytes and autonomous adenomas reveals suppression of negative feedbacks in tumorigenesis, Proceedings of the National Academy of Sciences, 2006, 103, 2, 413

    CrossRef

  14. 14
    Tetsuo Kondo, Shereen Ezzat, Sylvia L. Asa, Pathogenetic mechanisms in thyroid follicular-cell neoplasia, Nature Reviews Cancer, 2006, 6, 4, 292

    CrossRef

  15. 15
    Beatriz S. Stolf, Cintia M. Abreu, Maria B. Mahler-Araújo, Márcia Dellamano, Waleska K. Martins, Marcos Brasilino de Carvalho, Maria P. Curado, Juan P. Díaz, Artur Fabri, Helena Brentani, Alex F. Carvalho, Fernando A. Soares, Luiz P. Kowalski, Roberto Hirata, Luiz F.L. Reis, Expression profile of malignant and non-malignant diseases of the thyroid gland reveals altered expression of a common set of genes in goiter and papillary carcinomas, Cancer Letters, 2005, 227, 1, 59

    CrossRef

  16. 16
    Charis Eng, Frank Weber, Gene-expression profiling in differentiated thyroid cancer – a viable strategy for the practice of genomic medicine?, Future Oncology, 2005, 1, 4, 497

    CrossRef

  17. 17
    Thomas J Giordano, Rork Kuick, Dafydd G Thomas, David E Misek, Michelle Vinco, Donita Sanders, Zhaowen Zhu, Raffaele Ciampi, Michael Roh, Kerby Shedden, Paul Gauger, Gerard Doherty, Norman W Thompson, Samir Hanash, Ronald J Koenig, Yuri E Nikiforov, Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis, Oncogene, 2005, 24, 44, 6646

    CrossRef